|
1
|
Schmulson MW and Chang L: Diagnostic
approach to the patient with irritable bowel syndrome. Am J Med.
107:20S–26S. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holten KB, Wetherington A and Bankston L:
Diagnosing the patient with abdominal pain and altered bowel
habits: is it irritable bowel syndrome? Am Fam Physician.
67:2157–2164. 2003.PubMed/NCBI
|
|
3
|
Andresen V and Camilleri M: Irritable
bowel syndrome: recent and novel therapeutic approaches. Drugs.
66:1073–1088. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van der Veek PP, van den Berg M, de Kroon
YE, Verspaget HW and Masclee AA: Role of tumor necrosis
factor-alpha and interleukin-10 gene polymorphisms in irritable
bowel syndrome. Am J Gastroenterol. 100:2510–2516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonsalkorale WM, Perrey C, Pravica V,
Whorwell PJ and Hutchinson IV: Interleukin 10 genotypes in
irritable bowel syndrome: evidence for an inflammatory component?
Gut. 52:91–93. 2003. View Article : Google Scholar
|
|
6
|
Nielsen OH, Rüdiger N, Gaustadnes M and
Horn T: Intestinal interleukin-8 concentration and gene expression
in inflammatory bowel disease. Scand J Gastroenterol. 32:1028–1034.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Coëffier M, Gloro R, Boukhettala N, et al:
Increased proteasome-mediated degradation of occludin in irritable
bowel syndrome. Am J Gastroenterol. 105:1181–1188. 2010. View Article : Google Scholar
|
|
8
|
Simrén M, Abrahamsson H, Svedlund J and
Björnsson E: Quality of life in patients with irritable bowel
syndrome seen in referral centers versus primary care: the impact
of gender and predominant bowel pattern. Scand J Gastroenterol.
36:545–552. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piche T, Huet PM, Gelsi E, et al: Fatigue
in irritable bowel syndrome: characterization and putative role of
leptin. Eur J Gastroenterol Hepatol. 19:237–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piche T, Saint-Paul MC, Dainese R, et al:
Mast cells and cellularity of the colonic mucosa correlated with
fatigue and depression in irritable bowel syndrome. Gut.
57:468–473. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Drossman DA and Dumitrascu DL: Rome III:
New standard for functional gastrointestinal disorders. J
Gastrointestin Liver Dis. 15:237–241. 2006.PubMed/NCBI
|
|
12
|
Lewis SJ and Heaton KW: Stool form scale
as a useful guide to intestinal transit time. Scand J
Gastroenterol. 32:920–924. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Endo Y, Yoshizawa M, Fukudo S, Sasaki M
and Hongo M: Panic disorder in irritable bowel syndrome. Jpn J
Psychosom Med. 40:339–346. 2000.
|
|
14
|
Liebregts T, Adam B, Bredack C, et al:
Immune activation in patients with irritable bowel syndrome.
Gastroenterology. 132:913–920. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zung WW: A rating instrument for anxiety
disorders. Psychosomatics. 12:371–379. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zung WW: A self-rating depression scale.
Arch Gen Psychiatry. 12:63–70. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang L, Ameen VZ, Dukes GE, McSorley DJ,
Carter EG and Mayer EA: A dose-ranging, phase II study of the
efficacy and safety of alosetron in men with diarrhea-predominant
IBS. Am J Gastroenterol. 100:115–123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ohman L and Simrén M: Pathogenesis of IBS:
role of inflammation, immunity and neuroimmune interactions. Nat
Rev Gastroenterol Hepatol. 7:163–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamura M, Saito H, Kasanuki J, Tamura Y
and Yoshida S: Cytokine production in patients with inflammatory
bowel disease. Gut. 33:933–937. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gecse K, Roka R, Ferrier L, et al:
Increased faecal serine protease activity in diarrhoeic IBS
patients: a colonic lumenal factor impairing colonic permeability
and sensitivity. Gut. 57:591–599. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bertiaux-Vandaele N, Youmba SB, Belmonte
L, et al: The expression and the cellular distribution of the tight
junction proteins are altered in irritable bowel syndrome patients
with differences according to the disease subtype. Am J
Gastroenterol. 106:2165–2173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dunlop SP, Hebden J, Campbell E, et al:
Abnormal intestinal permeability in subgroups of
diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol.
101:1288–1294. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chadwick VS, Chen W, Shu D, et al:
Activation of the mucosal immune system in irritable bowel
syndrome. Gastroenterology. 122:1778–1783. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Woolf C, Allchorne A, Safieh-Garabedian B
and Poole S: Cytokines, nerve growth factor and inflammatory
hyperalgesia: the contribution of tumour necrosis factor alpha. Br
J Pharmacol. 121:417–424. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gao J: Correlation between
anxiety-depression status and cytokines in diarrhea-predominant
irritable bowel syndrome. Exp Ther Med. 6:93–96. 2013.PubMed/NCBI
|
|
26
|
Nicholl BI, Halder SL, Macfarlane GJ, et
al: Psychosocial risk markers for new onset irritable bowel
syndrome - results of a large prospective population-based study.
Pain. 137:147–155. 2008. View Article : Google Scholar :
|
|
27
|
Qiu BS, Vallance BA, Blennerhassett PA and
Collins SM: The role of CD4+ lymphocytes in the susceptibility of
mice to stress-induced reactivation of experimental colitis. Nat
Med. 5:1178–1182. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kiliaan AJ, Saunders PR, Bijlsma PB, et
al: Stress stimulates transepithelial macromolecular uptake in rat
jejunum. Am J Physiol. 275(5 Pt 1): G1037–G1044. 1998.PubMed/NCBI
|
